- Home
- SYBX vs ANGH Comparison
SYBX vs ANGH Comparison
Compare SYBX & ANGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYBX
- ANGH
- Stock Information
- Founded
- SYBX N/A
- ANGH 2012
- Country
- SYBX United States
- ANGH United Arab Emirates
- Employees
- SYBX N/A
- ANGH N/A
- Industry
- SYBX Biotechnology: Pharmaceutical Preparations
- ANGH Telecommunications Equipment
- Sector
- SYBX Health Care
- ANGH Consumer Discretionary
- Exchange
- SYBX Nasdaq
- ANGH Nasdaq
- Market Cap
- SYBX 20.0M
- ANGH 18.7M
- IPO Year
- SYBX N/A
- ANGH N/A
- Fundamental
- Price
- SYBX $1.75
- ANGH $2.90
- Analyst Decision
- SYBX
- ANGH
- Analyst Count
- SYBX 0
- ANGH 0
- Target Price
- SYBX N/A
- ANGH N/A
- AVG Volume (30 Days)
- SYBX 50.2K
- ANGH 5.3K
- Earning Date
- SYBX 11-11-2025
- ANGH 12-19-2025
- Dividend Yield
- SYBX N/A
- ANGH N/A
- EPS Growth
- SYBX N/A
- ANGH N/A
- EPS
- SYBX N/A
- ANGH N/A
- Revenue
- SYBX N/A
- ANGH $78,093,405.00
- Revenue This Year
- SYBX N/A
- ANGH N/A
- Revenue Next Year
- SYBX N/A
- ANGH N/A
- P/E Ratio
- SYBX N/A
- ANGH N/A
- Revenue Growth
- SYBX N/A
- ANGH 88.72
- 52 Week Low
- SYBX $0.90
- ANGH $2.53
- 52 Week High
- SYBX $1.96
- ANGH $9.40
- Technical
- Relative Strength Index (RSI)
- SYBX 49.98
- ANGH 52.11
- Support Level
- SYBX $1.52
- ANGH $2.80
- Resistance Level
- SYBX $1.86
- ANGH $2.84
- Average True Range (ATR)
- SYBX 0.12
- ANGH 0.06
- MACD
- SYBX -0.01
- ANGH 0.01
- Stochastic Oscillator
- SYBX 42.86
- ANGH 75.23
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.
About ANGH Anghami Inc.
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.